BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 14534360)

  • 1. Fructose-fed rats are protected against ischemia/reperfusion injury.
    Jordan JE; Simandle SA; Tulbert CD; Busija DW; Miller AW
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1007-11. PubMed ID: 14534360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the relationship between hyperinsulinaemia and myocardial ischaemia/reperfusion injury in a rat model of depression.
    Solskov L; Løfgren B; Pold R; Kristiansen SB; Nielsen TT; Overstreet DH; Schmitz O; Bøtker HE; Lund S; Wegener G
    Clin Sci (Lond); 2009 Nov; 118(4):259-67. PubMed ID: 19575693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
    Sivarajah A; McDonald MC; Thiemermann C
    Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK.
    Su H; Sun X; Ma H; Zhang HF; Yu QJ; Huang C; Wang XM; Luan RH; Jia GL; Wang HC; Gao F
    Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E629-35. PubMed ID: 17519283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning.
    Halkos ME; Kerendi F; Corvera JS; Wang NP; Kin H; Payne CS; Sun HY; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Ann Thorac Surg; 2004 Sep; 78(3):961-9; discussion 969. PubMed ID: 15337028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of cardioprotective effect of ischemic pre- and postconditioning in the hyperhomocysteinemic rat heart.
    Balakumar P; Rohilla A; Singh G; Singh K; Singh M
    Methods Find Exp Clin Pharmacol; 2009 Mar; 31(2):71-9. PubMed ID: 19455261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardioprotection of recombinant human erythropoietin pretreatment on ischemia-reperfused hearts and mechanism thereof: experiment with rats].
    Liu XM; Jia Z; Zhou ZQ; Xu JG
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2463-7. PubMed ID: 18067805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term aerobic exercise protects the heart against ischemia/reperfusion injury via PI3 kinase-dependent and Akt-mediated mechanism.
    Zhang KR; Liu HT; Zhang HF; Zhang QJ; Li QX; Yu QJ; Guo WY; Wang HC; Gao F
    Apoptosis; 2007 Sep; 12(9):1579-88. PubMed ID: 17505785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment with an adenosine A1 receptor agonist and lidocaine: a possible alternative to myocardial ischemic preconditioning.
    Canyon SJ; Dobson GP
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):371-7. PubMed ID: 16077401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
    Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Size of myocardial infarction induced by ischaemia/reperfusion is unaltered in rats with metabolic syndrome.
    Thim T; Bentzon JF; Kristiansen SB; Simonsen U; Andersen HL; Wassermann K; Falk E
    Clin Sci (Lond); 2006 Jun; 110(6):665-71. PubMed ID: 16448385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart.
    Burley DS; Baxter GF
    Basic Res Cardiol; 2007 Nov; 102(6):529-41. PubMed ID: 17896117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic preconditioning targets the reperfusion phase.
    Hausenloy DJ; Wynne AM; Yellon DM
    Basic Res Cardiol; 2007 Sep; 102(5):445-52. PubMed ID: 17530316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late protective effect of pharmacological preconditioning with total flavones of rhododendra against myocardial ischemia-reperfusion injury.
    Zhang JH; Chen ZW; Wu Z
    Can J Physiol Pharmacol; 2008 Mar; 86(3):131-8. PubMed ID: 18418440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNFalpha is required to confer protection in an in vivo model of classical ischaemic preconditioning.
    Deuchar GA; Opie LH; Lecour S
    Life Sci; 2007 Apr; 80(18):1686-91. PubMed ID: 17316703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fructose-fed rat hearts are protected against ischemia-reperfusion injury.
    Joyeux-Faure M; Rossini E; Ribuot C; Faure P
    Exp Biol Med (Maywood); 2006 Apr; 231(4):456-62. PubMed ID: 16565441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of insulin and glucose infusion on myocardial infarction size in uraemic rats.
    Dikow R; Wasserhess C; Zimmerer K; Kihm LP; Schaier M; Schwenger V; Hardt S; Tiefenbacher C; Katus H; Zeier M; Gross LM
    Basic Res Cardiol; 2009 Sep; 104(5):571-9. PubMed ID: 19288152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart.
    Das B; Sarkar C
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):277-86. PubMed ID: 16495767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardioprotective effect of isosteviol on rats with heart ischemia-reperfusion injury.
    Xu D; Li Y; Wang J; Davey AK; Zhang S; Evans AM
    Life Sci; 2007 Jan; 80(4):269-74. PubMed ID: 17055001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic preconditioning protects against gut dysfunction and mucosal injury after ischemia/reperfusion injury.
    Moore-Olufemi SD; Kozar RA; Moore FA; Sato N; Hassoun HT; Cox CS; Kone BC
    Shock; 2005 Mar; 23(3):258-63. PubMed ID: 15718925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.